CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $41,532 | -60.8% | 200,638 | 0.0% | 0.00% | – |
Q4 2022 | $105,837 | +3.8% | 200,638 | -0.7% | 0.00% | – |
Q3 2022 | $102,000 | -71.7% | 202,146 | 0.0% | 0.00% | – |
Q2 2022 | $360,000 | +151.7% | 202,146 | -6.8% | 0.00% | – |
Q1 2022 | $143,000 | +107.2% | 216,807 | +187.9% | 0.00% | – |
Q4 2021 | $69,000 | -77.7% | 75,309 | 0.0% | 0.00% | – |
Q3 2021 | $309,000 | -5.2% | 75,309 | 0.0% | 0.00% | – |
Q2 2021 | $326,000 | -52.6% | 75,309 | -44.8% | 0.00% | – |
Q1 2021 | $688,000 | +36.0% | 136,457 | +70.2% | 0.00% | – |
Q4 2020 | $506,000 | +50.1% | 80,174 | +2.2% | 0.00% | – |
Q3 2020 | $337,000 | -19.6% | 78,477 | +10.1% | 0.00% | – |
Q2 2020 | $419,000 | +270.8% | 71,293 | +175.3% | 0.00% | – |
Q1 2020 | $113,000 | -36.5% | 25,900 | -0.9% | 0.00% | – |
Q4 2019 | $178,000 | +39.1% | 26,139 | 0.0% | 0.00% | – |
Q3 2019 | $128,000 | -33.3% | 26,139 | 0.0% | 0.00% | – |
Q2 2019 | $192,000 | -59.3% | 26,139 | -55.0% | 0.00% | – |
Q1 2019 | $472,000 | -1.3% | 58,135 | -4.1% | 0.00% | – |
Q4 2018 | $478,000 | -39.8% | 60,647 | -17.7% | 0.00% | – |
Q3 2018 | $794,000 | +17.6% | 73,711 | +27.5% | 0.00% | – |
Q2 2018 | $675,000 | -15.5% | 57,811 | +86.6% | 0.00% | – |
Q1 2018 | $799,000 | +166.3% | 30,982 | +40.8% | 0.00% | – |
Q4 2017 | $300,000 | +170.3% | 21,998 | -0.3% | 0.00% | – |
Q3 2017 | $111,000 | +3.7% | 22,064 | -3.6% | 0.00% | – |
Q2 2017 | $107,000 | – | 22,891 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |